Investigational COVID-19 Vaccine Reported to be Well-Tolerated and Generates Immune Response in Older Adults
A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults. A…